Anžič, N., Krasniqi, F., Eberhardt, A., Tzankov, A., & Haslbauer, J. D. (2021). Ipilimumab and Pembrolizumab Mixed Response in a 41-Year-Old Patient with SMARCA4-Deficient Thoracic Sarcoma: An Interdisciplinary Case Study. Case Rep Oncol.
Chicago-stil citatAnžič, Nina, Fatime Krasniqi, Anna-Lena Eberhardt, Alexandar Tzankov, och Jasmin Dionne Haslbauer. "Ipilimumab and Pembrolizumab Mixed Response in a 41-Year-Old Patient With SMARCA4-Deficient Thoracic Sarcoma: An Interdisciplinary Case Study." Case Rep Oncol 2021.
MLA-referensAnžič, Nina, et al. "Ipilimumab and Pembrolizumab Mixed Response in a 41-Year-Old Patient With SMARCA4-Deficient Thoracic Sarcoma: An Interdisciplinary Case Study." Case Rep Oncol 2021.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.